Epoch Investment Partners Inc. trimmed its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 8.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 694,906 shares of the company's stock after selling 61,604 shares during the period. HCA Healthcare comprises about 1.2% of Epoch Investment Partners Inc.'s holdings, making the stock its 9th biggest holding. Epoch Investment Partners Inc. owned 0.29% of HCA Healthcare worth $240,125,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also modified their holdings of the company. Cheviot Value Management LLC purchased a new stake in shares of HCA Healthcare during the first quarter valued at $26,000. Atwood & Palmer Inc. purchased a new stake in HCA Healthcare in the 1st quarter worth about $28,000. Bartlett & CO. Wealth Management LLC lifted its stake in HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after acquiring an additional 80 shares in the last quarter. ORG Partners LLC lifted its stake in HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after acquiring an additional 86 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. lifted its stake in HCA Healthcare by 75.8% in the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock worth $40,000 after acquiring an additional 50 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.
HCA Healthcare Stock Up 0.6%
Shares of HCA traded up $2.50 during trading hours on Thursday, hitting $407.55. 965,359 shares of the company were exchanged, compared to its average volume of 1,154,093. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The company has a market cap of $95.36 billion, a PE ratio of 17.13, a PEG ratio of 1.27 and a beta of 1.39. The firm's 50 day moving average is $376.38 and its 200-day moving average is $356.08.
HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. During the same quarter in the previous year, the firm earned $5.50 EPS. The firm's revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.
HCA Healthcare Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's payout ratio is currently 12.11%.
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on HCA. Morgan Stanley reduced their price objective on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research note on Monday, July 28th. Cantor Fitzgerald restated an "overweight" rating and issued a $444.00 target price on shares of HCA Healthcare in a research note on Tuesday. Wolfe Research cut HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Stephens raised HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Finally, Wells Fargo & Company lowered their price target on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating for the company in a research note on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $401.83.
Read Our Latest Analysis on HCA
About HCA Healthcare
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Recommended Stories
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access